Patau syndrome

Patau syndrome
Chromosome 13
ICD-10	Q91.4-Q91.7
ICD-9	758.1
DiseasesDB	13373

WikiDoc Resources for Patau syndrome
Articles
Most recent articles on Patau syndrome Most cited articles on Patau syndrome Review articles on Patau syndrome Articles on Patau syndrome in N Eng J Med, Lancet, BMJ
Media
Powerpoint slides on Patau syndrome Images of Patau syndrome Photos of Patau syndrome Podcasts & MP3s on Patau syndrome Videos on Patau syndrome
Evidence Based Medicine
Cochrane Collaboration on Patau syndrome Bandolier on Patau syndrome TRIP on Patau syndrome
Clinical Trials
Ongoing Trials on Patau syndrome at Clinical Trials.gov Trial results on Patau syndrome Clinical Trials on Patau syndrome at Google
Guidelines / Policies / Govt
US National Guidelines Clearinghouse on Patau syndrome NICE Guidance on Patau syndrome NHS PRODIGY Guidance FDA on Patau syndrome CDC on Patau syndrome
Books
Books on Patau syndrome
News
Patau syndrome in the news Be alerted to news on Patau syndrome News trends on Patau syndrome
Commentary
Blogs on Patau syndrome
Definitions
Definitions of Patau syndrome
Patient Resources / Community
Patient resources on Patau syndrome Discussion groups on Patau syndrome Patient Handouts on Patau syndrome Directions to Hospitals Treating Patau syndrome Risk calculators and risk factors for Patau syndrome
Healthcare Provider Resources
Symptoms of Patau syndrome Causes & Risk Factors for Patau syndrome Diagnostic studies for Patau syndrome Treatment of Patau syndrome
Continuing Medical Education (CME)
CME Programs on Patau syndrome
International
Patau syndrome en Espanol Patau syndrome en Francais
Business
Patau syndrome in the Marketplace Patents on Patau syndrome
Experimental / Informatics
List of terms related to Patau syndrome

For patient information click here

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1];Associate Editor(s)-in-Chief: Kalsang Dolma, M.B.B.S.[2]

Synonyms and keywords: Bartholin-Patau syndrome; trisomy 13; trisomy D; Ullrich-Feichtiger syndrome

Overview

Patau syndrome is a chromosomal abnormality, a syndrome in which a patient has an additional chromosome 13 due to a non-disjunction of chromosomes during meiosis. The extra chromosome 13 disrupts the normal course of development, causing the characteristic features of Patau syndrome.

Historical Perspective

Trisomy 13 was first observed by Erasmus Bartholin in 1657, but the chromosomal nature of the disease was ascertained by Dr.Klaus Patau in 1960. The disease is named in his honor. Patau syndrome was also described in Pacific island tribes. These reports were thought to have been caused by radiation from atomic bomb tests. The tribes were temporarily moved before and during the test by an "x" amount of distance. They were then put back where they had been taken; all of this occurred before it was known how long, or even if, radiation still lingered on after a nuclear explosion.

Pathophysiology

Genetics

• Most cases of Patau's syndrome result from trisomy 13, which means each cell in the body has three copies of chromosome 13 instead of the usual two copies. A small percentage of cases occur when only some of the body's cells have an extra copy of chromosome 13, resulting in a mixed population of cells with a differing number of chromosomes, such cases are called mosaic Patau.
• Patau syndrome can also occur when part of chromosome 13 becomes attached to another chromosome (translocated) before or at conception. Affected people have two copies of chromosome 13, plus extra material from chromosome 13 attached to another chromosome. With a translocation, the person has a partial trisomy for chromosome 13 and often the physical signs of the syndrome differ from the typical Patau syndrome.
• Most cases of Patau syndrome are not inherited, but occur as random events during the formation of reproductive cells (eggs and sperm). An error in cell division called non-disjunction can result in reproductive cells with an abnormal number of chromosomes. For example, an egg or sperm cell may gain an extra copy of chromosome 13. If one of these atypical reproductive cells contributes to the genetic makeup of a child, the child will have an extra chromosome 13 in each of the body's cells.
• Mosaic Patau syndrome is also not inherited. It occurs as a random error during cell division early in fetal development. As a result, some of the body's cells have the usual two copies of chromosome 13, and other cells have three copies of the chromosome.
• Patau syndrome due to a translocation can be inherited. An unaffected person can carry a rearrangement of genetic material between chromosome 13 and another chromosome. This rearrangement is called a balanced translocation because there is no extra material from chromosome 13. Although they do not have signs of Patau syndrome, people who carry this type of balanced translocation are at an increased risk of having children with the condition.

Epidemiology and Demographics

Patau syndrome affects approximately 7 in 100,000 live births.

Risk Factors

• Like all non-disjunction diseases (Down syndrome, Edwards syndrome, etc...) the risk of disease in the offspring increases with maternal age at pregnancy.
• Unless one of the parents are carriers of a translocation the chances of a couple having another trisomy 13 affected child is less than 1% (less than that of Down Syndrome).

Screening

Laboratory Screening

• Maternal serum alpha-fetoprotein (AFP)
• Free or total beta-human chorionic gonadotropin (hCG)
• Unconjugated estriol
• Inhibin A
• Pregnancy-associated plasma protein A (PAPP-A)

Imaging

• Ultrasonography may show features of birth defects and growth restriction.
• Nuchal translucency measurement

Diagnostic Testing

• Amniocentesis: Done at 15 weeks of gestation
• Chorionic villus sampling (CVS): Done at 13 weeks of gestation.

Natural History, Complications and Prognosis

• Most embryos with trisomy 13 do not survive gestation and are spontaneously aborted.
• Of those surviving to term gestation, approximately 82-85% do not survive past 1 month of age, and 85% do not survive past 1 year of age.
• Certain malformations, especially holoprosencephaly and other central nervous system malformations, yield a more grave prognosis.
• Of those infants that survive past 1 year, most have few major malformations, but the prognosis remains poor, owing to multiple factors including long term neurological disability, feeding difficulty, and frequent pneumonia and other respiratory infections. Currently there are over 66 survivors of some form or another of Trisomy 13. See [3].

Diagnosis

Symptoms

• Seizures
• Vision problems

Physical Examination

Skin

• Cutis aplasia (missing portion of the skin/hair)

Head

• Microcephaly

Eyes

• Microphthalmia
• Cataract
• Iris and/or fundus (coloboma)
• Retinal detachment
• Nystagmus
• Optic nerve hypoplasia
• Hypertelorism

Ear

• Low-set ears

Throat

• Cleft lip or cleft palate
• Small lower jaw (micrognathia)

Abdomen

• Omphalocele (abdominal wall defect)

Extremities

• 

  A 37 2/7 week gestational age male infant with Patau syndrome demonstrating polydactyly

• Polydactyly (extra digits)
• Deformed feet known as rocker-bottom feet
• Single palmar crease
• Overlapping of fingers over thumb

Neurologic

• Mental and motor challenged
• Meningomyelocele (a spinal defect)
• Muscle hypotonia

Other

• Undescended testicle (cryptorchidism)
• Single umbilical artery

Laboratory Findings

Electrolyte and Biomarker Studies

• Low serum alpha fetoprotein levels

Echocardiography

• Ventricular septal defect

Ultrasound

• Kidney defects

MRI

• Holoprosencephaly (failure of the forebrain to divide properly)

Primary Prevention

Parents of infants with trisomy 13 that is caused by a translocation should have genetic testing and counseling, which may help them avoid having another child with the condition.

References

Template:WikiDoc Sources